Literature DB >> 27776015

From Pipe Dream to Donor-Specific PC Elimination: Novel Ways to Target Alloantibodies.

Anita S Chong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27776015      PMCID： PMC5088774          DOI： 10.1097/TP.0000000000001485

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells.

Authors:  Wing Y Lam; Amy M Becker; Krista M Kennerly; Rachel Wong; Jonathan D Curtis; Elizabeth M Llufrio; Kyle S McCommis; Johannes Fahrmann; Hannah A Pizzato; Ryan M Nunley; Jieun Lee; Michael J Wolfgang; Gary J Patti; Brian N Finck; Erika L Pearce; Deepta Bhattacharya
Journal:  Immunity       Date:  2016-07-05       Impact factor: 31.745

2.  Preventing Allograft Rejection by Targeting Immune Metabolism.

Authors:  Chen-Fang Lee; Ying-Chun Lo; Chih-Hsien Cheng; Georg J Furtmüller; Byoungchol Oh; Vinicius Andrade-Oliveira; Ajit G Thomas; Caitlyn E Bowman; Barbara S Slusher; Michael J Wolfgang; Gerald Brandacher; Jonathan D Powell
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

3.  CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif.

Authors:  Cheryl H Rozanski; Adam Utley; Louise M Carlson; Matthew R Farren; Megan Murray; Lisa M Russell; Jayakumar R Nair; ZhengYu Yang; William Brady; Lee Ann Garrett-Sinha; Stephen P Schoenberger; Jonathan M Green; Lawrence H Boise; Kelvin P Lee
Journal:  J Immunol       Date:  2015-04-01       Impact factor: 5.422

4.  Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Authors:  Jessica L Halliley; Christopher M Tipton; Jane Liesveld; Alexander F Rosenberg; Jaime Darce; Ivan V Gregoretti; Lana Popova; Denise Kaminiski; Christopher F Fucile; Igor Albizua; Shuya Kyu; Kuang-Yueh Chiang; Kyle T Bradley; Richard Burack; Mark Slifka; Erika Hammarlund; Hao Wu; Liping Zhao; Edward E Walsh; Ann R Falsey; Troy D Randall; Wan Cheung Cheung; Iñaki Sanz; F Eun-Hyung Lee
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

5.  Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation.

Authors:  Jinghui Yang; Jianjun Chen; James S Young; Qiang Wang; Dengping Yin; Roger Sciammas; Anita S Chong
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

6.  The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.

Authors:  Kirsten Neubert; Silke Meister; Katrin Moser; Florian Weisel; Damian Maseda; Kerstin Amann; Carsten Wiethe; Thomas H Winkler; Joachim R Kalden; Rudolf A Manz; Reinhard E Voll
Journal:  Nat Med       Date:  2008-06-08       Impact factor: 53.440

7.  Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients.

Authors:  Jianjun Chen; Qiang Wang; Dengping Yin; Vinh Vu; Roger Sciammas; Anita S Chong
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

Review 8.  Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation.

Authors:  Chris Wiebe; Peter Nickerson
Journal:  Curr Opin Organ Transplant       Date:  2013-08       Impact factor: 2.640

9.  Emerging concepts of T cell metabolism as a target of immunotherapy.

Authors:  Chih-Hao Chang; Erika L Pearce
Journal:  Nat Immunol       Date:  2016-04       Impact factor: 25.606

10.  The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients.

Authors:  Robert R Redfield; Joseph R Scalea; Tiffany J Zens; Didier A Mandelbrot; Glen Leverson; Dixon B Kaufman; Arjang Djamali
Journal:  Nephrol Dial Transplant       Date:  2016-07-06       Impact factor: 5.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.